3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Celiprolol.
Acebutolol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Celiprolol.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Celiprolol.
Advertisement
Acemetacin
The therapeutic efficacy of Celiprolol can be decreased when used in combination with Acemetacin.
Acepromazine
Acepromazine may increase the hypotensive activities of Celiprolol.
Aceprometazine
Aceprometazine may increase the hypotensive activities of Celiprolol.
Advertisement
Acetohexamide
Celiprolol may increase the hypoglycemic activities of Acetohexamide.
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Celiprolol.
Acetylcholine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Acetylcholine.
Advertisement
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Celiprolol is combined with Acetylcholine.
Acetyldigitoxin
Celiprolol may increase the bradycardic activities of Acetyldigitoxin.
Adapalene
Adapalene may decrease the antihypertensive activities of Celiprolol.
Albuterol
Celiprolol may decrease the bronchodilatory activities of Salbutamol.
Alfentanil
Alfentanil may increase the bradycardic activities of Celiprolol.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Celiprolol.
Aliskiren
Celiprolol may increase the hypotensive activities of Aliskiren.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Celiprolol.
Alprenolol
Alprenolol may decrease the bronchodilatory activities of Celiprolol.
Ambenonium
Ambenonium may increase the bradycardic activities of Celiprolol.
Ambrisentan
Celiprolol may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
Celiprolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Ambroxol-Theophylline-7-Acetate
Celiprolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Amifostine
Celiprolol may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Celiprolol may increase the hypotensive activities of Amifostine.
Amineptin
The risk or severity of adverse effects can be increased when Amineptine is combined with Celiprolol.
Aminophylline
Celiprolol may decrease the bronchodilatory activities of Aminophylline.
Amiodarone
The therapeutic efficacy of Celiprolol can be increased when used in combination with Amiodarone.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Celiprolol.
Amlodipine
Amlodipine may increase the hypotensive activities of Celiprolol.
Amobarbital
The serum concentration of Celiprolol can be decreased when it is combined with Amobarbital.
Amodiaquine
The metabolism of Celiprolol can be decreased when combined with Amodiaquine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Celiprolol.
Amphetamine
The risk or severity of adverse effects can be increased when Amphetamine is combined with Celiprolol.
Antipyrine
Antipyrine may decrease the antihypertensive activities of Celiprolol.
Apalutamide
The serum concentration of Celiprolol can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may decrease the antihypertensive activities of Celiprolol.
Apomorphine
Apomorphine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Apremilast
Apremilast may decrease the antihypertensive activities of Celiprolol.
Aprepitant
The serum concentration of Celiprolol can be increased when it is combined with Aprepitant.
Arbutamine
Celiprolol may decrease the bronchodilatory activities of Arbutamine.
Arformoterol
Celiprolol may decrease the bronchodilatory activities of Arformoterol.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Celiprolol.
Atazanavir
The metabolism of Celiprolol can be decreased when combined with Atazanavir.
Atenolol
Atenolol may increase the hypotensive activities of Celiprolol.
Atomoxetine
Atomoxetine may increase the hypertensive activities of Celiprolol.
Atosiban
The risk or severity of adverse effects can be increased when Celiprolol is combined with Atosiban.
Avanafil
Avanafil may increase the antihypertensive activities of Celiprolol.
Azelastine
Azelastine may decrease the antihypertensive activities of Celiprolol.
Azosemide
Celiprolol may increase the hypokalemic activities of Azosemide.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Celiprolol.
Bambuterol
Celiprolol may decrease the bronchodilatory activities of Bambuterol.
Barbexaclone
The serum concentration of Celiprolol can be decreased when it is combined with Barbexaclone.
Barbital
The serum concentration of Celiprolol can be decreased when it is combined with Barbital.
Benazepril
Benazepril may increase the hypotensive activities of Celiprolol.
Bendroflumethiazide
Celiprolol may increase the hypokalemic activities of Bendroflumethiazide.
Benzphetamine
Benzphetamine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Celiprolol.
Bepridil
Bepridil may increase the hypotensive activities of Celiprolol.
BETAHISTINE
The therapeutic efficacy of Celiprolol can be decreased when used in combination with Betahistine.
Betaxolol
Betaxolol may increase the hypotensive activities of Celiprolol.
Bethanechol
The risk or severity of adverse effects can be increased when Celiprolol is combined with Bethanechol.
Bethanidine
Bethanidine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Celiprolol.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Celiprolol.
Boceprevir
The metabolism of Celiprolol can be decreased when combined with Boceprevir.
Bopindolol
Bopindolol may decrease the bronchodilatory activities of Celiprolol.
Bortezomib
The metabolism of Celiprolol can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Celiprolol can be decreased when it is combined with Bosentan.
Bretylium
Bretylium may increase the hypotensive activities of Celiprolol.
Brimonidine
Brimonidine may increase the antihypertensive activities of Celiprolol.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Celiprolol.
Bromocriptine
Bromocriptine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Celiprolol.
Bumetanide
Celiprolol may increase the hypokalemic activities of Bumetanide.
Bunazosin
Celiprolol may increase the orthostatic hypotensive activities of Bunazosin.
Bupivacaine
The serum concentration of Bupivacaine can be increased when it is combined with Celiprolol.
Bupranolol
Bupranolol may decrease the bronchodilatory activities of Celiprolol.
Cabergoline
Celiprolol may increase the vasoconstricting activities of Cabergoline.
Cafedrine
Celiprolol may increase the hypotensive activities of Cafedrine.
Candesartan
Celiprolol may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Candesartan cilexetil may increase the hypotensive activities of Celiprolol.
Captopril
Captopril may increase the hypotensive activities of Celiprolol.
Carbachol
The risk or severity of adverse effects can be increased when Celiprolol is combined with Carbachol.
Carbamazepine
The metabolism of Celiprolol can be increased when combined with Carbamazepine.
Carprofen
Carprofen may decrease the antihypertensive activities of Celiprolol.
Carteolol
Carteolol may decrease the bronchodilatory activities of Celiprolol.
Carvedilol
Celiprolol may increase the orthostatic hypotensive activities of Carvedilol.
Celecoxib
Celecoxib may decrease the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Celiprolol can be increased when it is combined with Ceritinib.
Cevimeline
The risk or severity of adverse effects can be increased when Celiprolol is combined with Cevimeline.
Chloroquine
The metabolism of Celiprolol can be decreased when combined with Chloroquine.
Chlorothiazide
Celiprolol may increase the hypokalemic activities of Chlorothiazide.
Chlorpromazine
Chlorpromazine may increase the hypotensive activities of Celiprolol.
Chlorpropamide
Celiprolol may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
Celiprolol may increase the hypokalemic activities of Chlorthalidone.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Celiprolol.
Cicletanine
Celiprolol may increase the hypotensive activities of Cicletanine.
Cilazapril
Cilazapril may increase the hypotensive activities of Celiprolol.
Clarithromycin
The metabolism of Celiprolol can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Celiprolol can be decreased when combined with Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Clenbuterol is combined with Celiprolol.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Celiprolol.
Clonidine
Clonidine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Clonixin
Clonixin may decrease the antihypertensive activities of Celiprolol.
Clotrimazole
The metabolism of Celiprolol can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Celiprolol can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Celiprolol.
Crizotinib
The metabolism of Celiprolol can be decreased when combined with Crizotinib.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Celiprolol.
Curcumin
Curcumin may decrease the antihypertensive activities of Celiprolol.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Celiprolol.
Cyclopenthiazide
Celiprolol may increase the hypokalemic activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Celiprolol can be decreased when combined with Cyclosporine.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Celiprolol.
Dabrafenib
The serum concentration of Celiprolol can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Celiprolol can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Celiprolol can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Celiprolol can be increased when it is combined with Dasatinib.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Celiprolol.
Deferasirox
The serum concentration of Celiprolol can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Celiprolol can be decreased when combined with Delavirdine.
Demecarium
Demecarium may increase the bradycardic activities of Celiprolol.
Deserpidine
Celiprolol may increase the hypotensive activities of Deserpidine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Celiprolol.
Deslanoside
Celiprolol may increase the bradycardic activities of Deslanoside.
Desvenlafaxine
The serum concentration of Celiprolol can be increased when it is combined with Desvenlafaxine.
Dexmedetomidine
Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Diazoxide
Diazoxide may increase the hypotensive activities of Celiprolol.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Celiprolol.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Celiprolol.
Digitoxin
Celiprolol may increase the bradycardic activities of Digitoxin.
Digoxin
Celiprolol may increase the bradycardic activities of Digoxin.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Celiprolol.
Dihydroergotamine
Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Diltiazem
The metabolism of Celiprolol can be decreased when combined with Diltiazem.
Dipivefrin
Dipivefrin may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Dipyridamole
Dipyridamole may increase the bradycardic activities of Celiprolol.
Dipyrone
Metamizole may decrease the antihypertensive activities of Celiprolol.
Disopyramide
Disopyramide may increase the bradycardic activities of Celiprolol.
Distigmine
Distigmine may increase the bradycardic activities of Celiprolol.
Dobutamine
The risk or severity of adverse effects can be increased when Dobutamine is combined with Celiprolol.
Donepezil
Donepezil may increase the bradycardic activities of Celiprolol.
Dopamine
The risk or severity of adverse effects can be increased when Dopamine is combined with Celiprolol.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Celiprolol.
Dothiepin
The risk or severity of adverse effects can be increased when Dosulepin is combined with Celiprolol.
Doxazosin
Celiprolol may increase the orthostatic hypotensive activities of Doxazosin.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Celiprolol.
Doxycycline
The metabolism of Celiprolol can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Celiprolol can be decreased when combined with Doxycycline.
Dronedarone
Dronedarone may increase the bradycardic activities of Celiprolol.
Droxicam
Droxicam may decrease the antihypertensive activities of Celiprolol.
Droxidopa
Droxidopa may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Duloxetine
The serum concentration of Celiprolol can be increased when it is combined with Duloxetine.
Dyphylline
Celiprolol may decrease the bronchodilatory activities of Dyphylline.
Echothiophate
Echothiophate may increase the bradycardic activities of Celiprolol.
Edrophonium
Edrophonium may increase the bradycardic activities of Celiprolol.
Enalapril
Enalapril may increase the hypotensive activities of Celiprolol.
Enalaprilat
Celiprolol may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Celiprolol may increase the hypotensive activities of Enalaprilat.
Enzalutamide
The serum concentration of Celiprolol can be decreased when it is combined with Enzalutamide.
Ephedrine
The risk or severity of adverse effects can be increased when Ephedrine is combined with Celiprolol.
Epinephrine
Epinephrine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Epoprostenol
Epoprostenol may increase the hypotensive activities of Celiprolol.
Eprosartan
Eprosartan may increase the hypotensive activities of Celiprolol.
ergoloid mesylates, USP
Celiprolol may increase the vasoconstricting activities of Ergoloid mesylate.
Ergonovine
Celiprolol may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Ergotamine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Erythromycin
The metabolism of Celiprolol can be decreased when combined with Erythromycin.
Esmolol
Esmolol may decrease the bronchodilatory activities of Celiprolol.
Etanercept
Etanercept may decrease the antihypertensive activities of Celiprolol.
Ethacrynate
Celiprolol may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Celiprolol may increase the hypokalemic activities of Etacrynic acid.
Etilefrine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Etilefrine.
Etodolac
Etodolac may decrease the antihypertensive activities of Celiprolol.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Celiprolol.
Etomidate
Etomidate may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Etoricoxib
Etoricoxib may decrease the antihypertensive activities of Celiprolol.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Celiprolol.
Felbinac
Felbinac may decrease the antihypertensive activities of Celiprolol.
Felodipine
Felodipine may increase the hypotensive activities of Celiprolol.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Celiprolol.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Celiprolol.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Celiprolol.
Fenoterol
The risk or severity of adverse effects can be increased when Fenoterol is combined with Celiprolol.
Fentanyl
Fentanyl may increase the bradycardic activities of Celiprolol.
Ferulic Acid
Celiprolol may increase the hypotensive activities of Ferulic acid.
Fingolimod
Celiprolol may increase the bradycardic activities of Fingolimod.
Floctafenine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Floctafenine.
Fluconazole
The metabolism of Celiprolol can be decreased when combined with Fluconazole.
Fluoxetine
The serum concentration of Celiprolol can be increased when it is combined with Fluoxetine.
Fluphenazine
Fluphenazine may increase the hypotensive activities of Celiprolol.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Celiprolol.
Fluvoxamine
The metabolism of Celiprolol can be decreased when combined with Fluvoxamine.
Formoterol
Celiprolol may decrease the bronchodilatory activities of Formoterol.
Fosamprenavir
The metabolism of Celiprolol can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Celiprolol can be increased when it is combined with Fosaprepitant.
Fosinopril
Fosinopril may increase the hypotensive activities of Celiprolol.
Fosphenytoin
The metabolism of Celiprolol can be increased when combined with Fosphenytoin.
Furazolidone
Furazolidone may increase the hypotensive activities of Celiprolol.
Furosemide
Celiprolol may increase the hypokalemic activities of Furosemide.
Fusidate
The serum concentration of Celiprolol can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Celiprolol can be increased when it is combined with Fusidic Acid.
Galantamine
Galantamine may increase the bradycardic activities of Celiprolol.
Gallamine Triethiodide
Gallamine Triethiodide may increase the bradycardic activities of Celiprolol.
Ginkgo biloba extract
Ginkgo biloba may increase the bradycardic activities of Celiprolol.
Glibornuride
Celiprolol may increase the hypoglycemic activities of Glibornuride.
Gliclazide
Celiprolol may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Celiprolol may increase the hypoglycemic activities of Glimepiride.
Glipizide
Celiprolol may increase the hypoglycemic activities of Glipizide.
Gliquidone
Celiprolol may increase the hypoglycemic activities of Gliquidone.
Glyburide
Celiprolol may increase the hypoglycemic activities of Glyburide.
Guanabenz
Guanabenz may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Guanadrel
Guanadrel may increase the hypotensive activities of Celiprolol.
Guanethidine
Guanethidine may increase the hypotensive activities of Celiprolol.
Guanfacine
Guanfacine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Hexobarbital
The serum concentration of Celiprolol can be decreased when it is combined with Hexobarbital.
Hydralazine
Hydralazine may increase the hypotensive activities of Celiprolol.
Hydrochlorothiazide
Celiprolol may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Celiprolol may increase the hypokalemic activities of Hydroflumethiazide.
Hydroxychloroquine
The metabolism of Celiprolol can be decreased when combined with Hydroxychloroquine.
Hypoxis hemerocallidea root extract
The serum concentration of Celiprolol can be decreased when it is combined with St. John's Wort.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Celiprolol.
Icatibant
Icatibant may decrease the antihypertensive activities of Celiprolol.
Idelalisib
The metabolism of Celiprolol can be decreased when combined with Idelalisib.
Iloprost
Iloprost may increase the hypotensive activities of Celiprolol.
Imatinib
The metabolism of Celiprolol can be decreased when combined with Imatinib.
Imidapril
Celiprolol may increase the hypotensive activities of Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Celiprolol.
Indacaterol
Celiprolol may decrease the bronchodilatory activities of Indacaterol.
Indapamide
Celiprolol may increase the hypokalemic activities of Indapamide.
Indinavir
The metabolism of Celiprolol can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Celiprolol can be decreased when combined with Indinavir.
Indobufen
Indobufen may decrease the antihypertensive activities of Celiprolol.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Celiprolol.
Indoramin
Celiprolol may increase the orthostatic hypotensive activities of Indoramin.
insulin human, rDNA origin
Celiprolol may increase the hypoglycemic activities of Insulin Human.
Insulin, Pork
Celiprolol may increase the hypoglycemic activities of Insulin Pork.
Insulin, Regular, Pork
Celiprolol may increase the hypoglycemic activities of Insulin Pork.
Iproniazid
Iproniazid may increase the hypotensive activities of Celiprolol.
Irbesartan
Irbesartan may increase the hypotensive activities of Celiprolol.
Isavuconazole
The serum concentration of Celiprolol can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Celiprolol can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Celiprolol.
Isoetharine
Celiprolol may decrease the bronchodilatory activities of Isoetarine.
Isoflurophate
Isoflurophate may increase the bradycardic activities of Celiprolol.
Isoproterenol
The risk or severity of adverse effects can be increased when Isoprenaline is combined with Celiprolol.
Isoxsuprine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Isoxsuprine.
Isradipine
The metabolism of Celiprolol can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Celiprolol can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Celiprolol can be increased when it is combined with Ivacaftor.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Celiprolol.
Ketanserin
Ketanserin may increase the hypotensive activities of Celiprolol.
Ketoconazole
The metabolism of Celiprolol can be decreased when combined with Ketoconazole.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Celiprolol.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Celiprolol.
Labetalol
Celiprolol may increase the orthostatic hypotensive activities of Labetalol.
Lacidipine
Celiprolol may increase the hypotensive activities of Lacidipine.
Latanoprost
Latanoprost may increase the hypotensive activities of Celiprolol.
Leflunomide
Leflunomide may decrease the antihypertensive activities of Celiprolol.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Celiprolol.
Levalbuterol
Celiprolol may decrease the bronchodilatory activities of Levosalbutamol.
Levomilnacipran
The serum concentration of Celiprolol can be increased when it is combined with Levomilnacipran.
Levonordefrin
Levonordefrin may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Lidocaine
The serum concentration of Lidocaine can be increased when it is combined with Celiprolol.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Celiprolol.
Linezolid
Linezolid may increase the hypertensive activities of Celiprolol.
Lisinopril
Lisinopril may increase the hypotensive activities of Celiprolol.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Celiprolol.
Lobeline
The risk or severity of adverse effects can be increased when Celiprolol is combined with Lobeline.
Lofexidine
Lofexidine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Lopinavir
The metabolism of Celiprolol can be decreased when combined with Lopinavir.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Celiprolol.
Losartan
Losartan may increase the hypotensive activities of Celiprolol.
Lovastatin
The metabolism of Celiprolol can be decreased when combined with Lovastatin.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Celiprolol.
Luliconazole
The serum concentration of Celiprolol can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Celiprolol can be increased when combined with Lumacaftor.
Macitentan
Celiprolol may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Celiprolol.
Malathion
Malathion may increase the bradycardic activities of Celiprolol.
Manidipine
Celiprolol may increase the hypotensive activities of Manidipine.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Celiprolol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Celiprolol.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Celiprolol.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Celiprolol.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Celiprolol.
Mefloquine
Mefloquine may increase the bradycardic activities of Celiprolol.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Celiprolol.
Memantine
Memantine may increase the bradycardic activities of Celiprolol.
Mephentermine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Celiprolol.
Mephobarbital
The serum concentration of Celiprolol can be decreased when it is combined with Methylphenobarbital.
Mepirodipine
Celiprolol may increase the antihypertensive activities of Barnidipine.
Mepivacaine
The serum concentration of Mepivacaine can be increased when it is combined with Celiprolol.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Celiprolol.
Mesoridazine
Mesoridazine may increase the hypotensive activities of Celiprolol.
Metaproterenol
The risk or severity of adverse effects can be increased when Orciprenaline is combined with Celiprolol.
Metaraminol
The risk or severity of adverse effects can be increased when Metaraminol is combined with Celiprolol.
Methacholine
Celiprolol may increase the bronchoconstrictory activities of Methacholine.
Methamphetamine
Methamphetamine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Methohexital
The serum concentration of Celiprolol can be decreased when it is combined with Methohexital.
Methotrimeprazine
Methotrimeprazine may increase the hypotensive activities of Celiprolol.
Methoxamine
The risk or severity of adverse effects can be increased when Methoxamine is combined with Celiprolol.
Methyclothiazide
Celiprolol may increase the hypokalemic activities of Methyclothiazide.
Methyldopa
Methyldopa may increase the hypotensive activities of Celiprolol.
METHYLDOPA ANHYDROUS
Methyldopa may increase the hypotensive activities of Celiprolol.
Methylene blue
Methylene blue may increase the hypotensive activities of Celiprolol.
Methylergonovine
Celiprolol may increase the vasoconstricting activities of Methylergometrine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Celiprolol.
Metipranolol
Metipranolol may increase the hypotensive activities of Celiprolol.
Metoclopramide
Metoclopramide may increase the bradycardic activities of Celiprolol.
Metolazone
Celiprolol may increase the hypokalemic activities of Metolazone.
Metoprolol
Metoprolol may increase the hypotensive activities of Celiprolol.
Metyrosine
Celiprolol may increase the hypotensive activities of Metyrosine.
Mibefradil
Mibefradil may increase the hypotensive activities of Celiprolol.
Midodrine
Celiprolol may increase the bradycardic activities of Midodrine.
Mifepristone
The serum concentration of Celiprolol can be increased when it is combined with Mifepristone.
Milnacipran
The serum concentration of Celiprolol can be increased when it is combined with Milnacipran.
Minaprine
Minaprine may increase the bradycardic activities of Celiprolol.
Minoxidil
Minoxidil may increase the hypotensive activities of Celiprolol.
Mirtazapine
The risk or severity of adverse effects can be increased when Mirtazapine is combined with Celiprolol.
Mitotane
The serum concentration of Celiprolol can be decreased when it is combined with Mitotane.
Moclobemide
Moclobemide may increase the hypotensive activities of Celiprolol.
Moexipril
Moexipril may increase the hypotensive activities of Celiprolol.
Molsidomine
Molsidomine may increase the hypotensive activities of Celiprolol.
Moricizine
Moricizine may increase the hypotensive activities of Celiprolol.
Moxonidine
Moxonidine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Celiprolol.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Celiprolol.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Celiprolol.
Nabilone
Nabilone may increase the tachycardic activities of Celiprolol.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Celiprolol.
Nadolol
Nadolol may increase the hypotensive activities of Celiprolol.
Naftifine
Naftifine may decrease the antihypertensive activities of Celiprolol.
Naphazoline
Naphazoline may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Naproxen
Naproxen may decrease the antihypertensive activities of Celiprolol.
Nebivolol
Celiprolol may increase the hypotensive activities of Nebivolol.
Nefazodone
The metabolism of Celiprolol can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Celiprolol can be decreased when combined with Nelfinavir.
Neostigmine
Neostigmine may increase the bradycardic activities of Celiprolol.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Celiprolol.
Netupitant
The serum concentration of Celiprolol can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Celiprolol can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive activities of Celiprolol.
Nicardipine
Nicardipine may increase the hypotensive activities of Celiprolol.
Nicorandil
Celiprolol may increase the hypotensive activities of Nicorandil.
Nicotine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Nicotine.
Nicotine Polacrilex
The risk or severity of adverse effects can be increased when Celiprolol is combined with Nicotine.
Nifedipine
The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Celiprolol.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Celiprolol.
Nilotinib
The metabolism of Celiprolol can be decreased when combined with Nilotinib.
Nilvadipine
Celiprolol may increase the hypotensive activities of Nilvadipine.
Nimesulide
Nimesulide may decrease the antihypertensive activities of Celiprolol.
Nimodipine
Nimodipine may increase the hypotensive activities of Celiprolol.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Celiprolol.
Nitrendipine
Nitrendipine may increase the hypotensive activities of Celiprolol.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Celiprolol.
Norepinephrine
Norepinephrine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Celiprolol.
Nylidrin
The risk or severity of adverse effects can be increased when Celiprolol is combined with Nylidrin.
O-PHENANTHROLINE
1,10-Phenanthroline may increase the bradycardic activities of Celiprolol.
Obinutuzumab
Celiprolol may increase the hypotensive activities of Obinutuzumab.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Celiprolol.
Olaparib
The metabolism of Celiprolol can be decreased when combined with Olaparib.
Olmesartan
Olmesartan may increase the hypotensive activities of Celiprolol.
Olodaterol
Celiprolol may decrease the bronchodilatory activities of Olodaterol.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Celiprolol.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Celiprolol.
Opipramol
The risk or severity of adverse effects can be increased when Opipramol is combined with Celiprolol.
Osimertinib
The serum concentration of Celiprolol can be increased when it is combined with Osimertinib.
Ouabain
Celiprolol may increase the bradycardic activities of Ouabain.
Ovine Digoxin Immune Fab
Celiprolol may increase the bradycardic activities of Digoxin Immune Fab (Ovine).
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Celiprolol.
Oxprenolol
Oxprenolol may decrease the bronchodilatory activities of Celiprolol.
Oxymetazoline
Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Celiprolol.
p-Hydroxyamphetamine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Hydroxyamphetamine.
Palbociclib
The serum concentration of Celiprolol can be increased when it is combined with Palbociclib.
Paliperidone
Paliperidone may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Celiprolol.
Pargyline
Pargyline may increase the hypotensive activities of Celiprolol.
Paroxetine
The serum concentration of Celiprolol can be increased when it is combined with Paroxetine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Celiprolol.
Penbutolol
Penbutolol may increase the hypotensive activities of Celiprolol.
Pentobarbital
The metabolism of Celiprolol can be increased when combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Celiprolol.
Perazine
Perazine may increase the hypotensive activities of Celiprolol.
Pergolide
Pergolide may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Periciazine
Propericiazine may increase the hypotensive activities of Celiprolol.
Perindopril
Perindopril may increase the hypotensive activities of Celiprolol.
Perphenazine
Perphenazine may increase the hypotensive activities of Celiprolol.
Phenelzine
Phenelzine may increase the hypotensive activities of Celiprolol.
Phenmetrazine
The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Celiprolol.
Phenobarbital
The metabolism of Celiprolol can be increased when combined with Phenobarbital.
Phenoxybenzamine
Phenoxybenzamine may increase the hypotensive activities of Celiprolol.
Phentermine
The risk or severity of adverse effects can be increased when Phentermine is combined with Celiprolol.
PHENTERMINE RESIN
The risk or severity of adverse effects can be increased when Phentermine is combined with Celiprolol.
Phentolamine
Phentolamine may increase the hypotensive activities of Celiprolol.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Celiprolol.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Celiprolol.
Phenylephrine
The risk or severity of adverse effects can be increased when Phenylephrine is combined with Celiprolol.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Celiprolol.
Phenytoin
The metabolism of Celiprolol can be increased when combined with Phenytoin.
Physostigmine
Physostigmine may increase the bradycardic activities of Celiprolol.
Pilocarpine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Pilocarpine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Celiprolol.
Pinacidil
Pinacidil may increase the hypotensive activities of Celiprolol.
Pindolol
Pindolol may increase the hypotensive activities of Celiprolol.
Pirbuterol
Celiprolol may decrease the bronchodilatory activities of Pirbuterol.
Piretanide
Celiprolol may increase the hypokalemic activities of Piretanide.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Celiprolol.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Celiprolol.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Celiprolol.
Polythiazide
Celiprolol may increase the hypokalemic activities of Polythiazide.
Posaconazole
The metabolism of Celiprolol can be decreased when combined with Posaconazole.
Prazosin
Celiprolol may increase the orthostatic hypotensive activities of Prazosin.
Primaquine
The metabolism of Celiprolol can be decreased when combined with Primaquine.
Primidone
The metabolism of Celiprolol can be increased when combined with Primidone.
Procarbazine
Procarbazine may increase the hypotensive activities of Celiprolol.
Procaterol
The risk or severity of adverse effects can be increased when Procaterol is combined with Celiprolol.
Prochlorperazine
Prochlorperazine may increase the hypotensive activities of Celiprolol.
Promazine
Promazine may increase the hypotensive activities of Celiprolol.
Promethazine
Promethazine may increase the hypotensive activities of Celiprolol.
Propafenone
The serum concentration of Celiprolol can be increased when it is combined with Propafenone.
Propranolol
Propranolol may increase the hypotensive activities of Celiprolol.
Proscillaridin
Celiprolol may increase the bradycardic activities of Proscillaridin.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Celiprolol.
Pseudoephedrine
Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Pyridostigmine
Pyridostigmine may increase the bradycardic activities of Celiprolol.
Pyridostigmine Bromide
Pyridostigmine may increase the bradycardic activities of Celiprolol.
Quinapril
Quinapril may increase the hypotensive activities of Celiprolol.
Quinethazone
Celiprolol may increase the hypokalemic activities of Quinethazone.
Quinine
Quinine may increase the hypotensive activities of Celiprolol.
Racepinephrine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Racepinephrine.
Ramipril
Ramipril may increase the hypotensive activities of Celiprolol.
Ranolazine
The metabolism of Celiprolol can be decreased when combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypotensive activities of Celiprolol.
Regorafenib
Regorafenib may increase the bradycardic activities of Celiprolol.
Regular Insulin, Human
Celiprolol may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the bradycardic activities of Celiprolol.
Rescinnamine
Celiprolol may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Celiprolol.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Celiprolol.
Rifabutin
The metabolism of Celiprolol can be increased when combined with Rifabutin.
Rifampin
The metabolism of Celiprolol can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Celiprolol can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Celiprolol can be decreased when it is combined with Rifaximin.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Celiprolol.
Riociguat
Celiprolol may increase the hypotensive activities of Riociguat.
Risperidone
Risperidone may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Ritodrine
The risk or severity of adverse effects can be increased when Ritodrine is combined with Celiprolol.
Rituximab
Celiprolol may increase the hypotensive activities of Rituximab.
Rivastigmine
Celiprolol may increase the bradycardic activities of Rivastigmine.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Celiprolol.
Ropinirole
Ropinirole may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Rucaparib
The metabolism of Celiprolol can be decreased when combined with Rucaparib.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Celiprolol.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Celiprolol.
Salmeterol
Celiprolol may decrease the bronchodilatory activities of Salmeterol.
Salsalate
Salsalate may decrease the antihypertensive activities of Celiprolol.
Saquinavir
The metabolism of Celiprolol can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Celiprolol can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Celiprolol can be decreased when used in combination with Sarilumab.
Secobarbital
The serum concentration of Celiprolol can be decreased when it is combined with Secobarbital.
Selegiline
Selegiline may increase the hypotensive activities of Celiprolol.
Selexipag
Celiprolol may increase the hypotensive activities of Selexipag.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Celiprolol.
Sertraline
The serum concentration of Celiprolol can be increased when it is combined with Sertraline.
Sildenafil
Sildenafil may increase the antihypertensive activities of Celiprolol.
Silodosin
Celiprolol may increase the orthostatic hypotensive activities of Silodosin.
Siltuximab
The serum concentration of Celiprolol can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Celiprolol can be increased when it is combined with Simeprevir.
Spirapril
Spirapril may increase the hypotensive activities of Celiprolol.
ST. JOHN'S WORT EXTRACT
The serum concentration of Celiprolol can be decreased when it is combined with St. John's Wort.
Sufentanil
Sufentanil may increase the bradycardic activities of Celiprolol.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Celiprolol.
Sulfisoxazole
The metabolism of Celiprolol can be decreased when combined with Sulfisoxazole.
Sulindac
Sulindac may decrease the antihypertensive activities of Celiprolol.
Suprofen
Suprofen may decrease the antihypertensive activities of Celiprolol.
Synephrine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Synephrine.
Tacrine
Tacrine may increase the bradycardic activities of Celiprolol.
Tadalafil
Tadalafil may increase the antihypertensive activities of Celiprolol.
Talinolol
Celiprolol may increase the hypotensive activities of Talinolol.
Tamsulosin
Celiprolol may increase the orthostatic hypotensive activities of Tamsulosin.
Tedizolid
Tedizolid Phosphate may increase the hypertensive activities of Celiprolol.
Tedizolid Phosphate
Tedizolid Phosphate may increase the hypertensive activities of Celiprolol.
Telaprevir
The metabolism of Celiprolol can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Celiprolol can be decreased when combined with Telithromycin.
Telmisartan
Telmisartan may increase the hypotensive activities of Celiprolol.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Celiprolol.
Terazosin
Celiprolol may increase the orthostatic hypotensive activities of Terazosin.
Terbutaline
The risk or severity of adverse effects can be increased when Terbutaline is combined with Celiprolol.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Terbutaline is combined with Celiprolol.
Teriflunomide
Teriflunomide may decrease the antihypertensive activities of Celiprolol.
Terlipressin
Terlipressin may increase the hypotensive activities of Celiprolol.
Tetrahydrocannabinol
Dronabinol may increase the tachycardic activities of Celiprolol.
Tetrahydrozoline
The risk or severity of adverse effects can be increased when Celiprolol is combined with Tetryzoline.
Theodrenaline
Celiprolol may increase the hypotensive activities of Theodrenaline.
Theophylline
Celiprolol may decrease the bronchodilatory activities of Theophylline.
Theophylline anhydrous
Celiprolol may decrease the bronchodilatory activities of Theophylline.
Thiamylal
The serum concentration of Celiprolol can be decreased when it is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Celiprolol.
Thiopental
The serum concentration of Celiprolol can be decreased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Celiprolol can be decreased when it is combined with Thiopental.
Thioproperazine
Thioproperazine may increase the hypotensive activities of Celiprolol.
Thioridazine
Thioridazine may increase the hypotensive activities of Celiprolol.
Tianeptine
The risk or severity of adverse effects can be increased when Tianeptine is combined with Celiprolol.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Celiprolol.
Tibolone
Celiprolol may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Celiprolol can be decreased when combined with Ticlopidine.
Timolol
Timolol may decrease the bronchodilatory activities of Celiprolol.
Timolol Anhydrous
Timolol may decrease the bronchodilatory activities of Celiprolol.
Tizanidine
Tizanidine may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Tocilizumab
The serum concentration of Celiprolol can be decreased when it is combined with Tocilizumab.
Tolazamide
Celiprolol may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Tolazoline may increase the hypotensive activities of Celiprolol.
Tolbutamide
Celiprolol may increase the hypoglycemic activities of Tolbutamide.
Tolfenamic Acid
Tolfenamic Acid may decrease the antihypertensive activities of Celiprolol.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Celiprolol.
Toloxatone
Toloxatone may increase the hypotensive activities of Celiprolol.
Torsemide
Celiprolol may increase the hypokalemic activities of Torasemide.
Tramazoline
The risk or severity of adverse effects can be increased when Celiprolol is combined with Tramazoline.
Trandolapril
Trandolapril may increase the hypotensive activities of Celiprolol.
Tranilast
Tranilast may decrease the antihypertensive activities of Celiprolol.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Celiprolol.
Travoprost
Travoprost may increase the hypotensive activities of Celiprolol.
Treprostinil
Treprostinil may increase the hypotensive activities of Celiprolol.
Trichlormethiazide
Celiprolol may increase the hypokalemic activities of Trichlormethiazide.
Trifluoperazine
Trifluoperazine may increase the hypotensive activities of Celiprolol.
Triflupromazine
Triflupromazine may increase the hypotensive activities of Celiprolol.
Trimeprazine
Alimemazine may increase the hypotensive activities of Celiprolol.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Celiprolol.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Celiprolol.
Tubocurarine
Tubocurarine may increase the bradycardic activities of Celiprolol.
Tyramine
The risk or severity of adverse effects can be increased when Celiprolol is combined with Tyramine.
UNOPROSTONE
Celiprolol may increase the hypotensive activities of Unoprostone.
Urapidil
Celiprolol may increase the orthostatic hypotensive activities of Urapidil.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Celiprolol.
Valsartan
Valsartan may increase the hypotensive activities of Celiprolol.
Vardenafil
Vardenafil may increase the antihypertensive activities of Celiprolol.
Varenicline
The risk or severity of adverse effects can be increased when Celiprolol is combined with Varenicline.
Vemurafenib
The serum concentration of Celiprolol can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Celiprolol can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Celiprolol can be decreased when combined with Verapamil.
Vilanterol
Celiprolol may decrease the bronchodilatory activities of Vilanterol.
Vincamine
Celiprolol may increase the hypotensive activities of Vincamine.
Vinpocetine
Celiprolol may increase the hypotensive activities of Vinpocetine.
Voriconazole
The metabolism of Celiprolol can be decreased when combined with Voriconazole.
Xylometazoline
Xylometazoline may increase the atrioventricular blocking (AV block) activities of Celiprolol.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Celiprolol.
Zileuton
Zileuton may decrease the antihypertensive activities of Celiprolol.
Ziprasidone
The metabolism of Celiprolol can be decreased when combined with Ziprasidone.
Zofenopril
Celiprolol may increase the hypotensive activities of Zofenopril.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Celiprolol.
